Vise Technologies’s CareDx CDNA Stock Holding History

Vise Technologies’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$355K	Buy	+5,466	New	+$248K	﹤0.01%	1582

Other funds holding CDNA

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return

Lisanti Capital Growth New York $373M AUM 178.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

ARS Investment Partners New York $2.23B AUM 74.02% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Vise Technologies's CDNA Position: Q3 2026 in Review

Vise Technologies opened a new position in CareDx (CDNA) in Q3 2026: 5,466 shares worth $355K. The stake represents ﹤0.01% of the portfolio and ranks #1582 among its holdings.

95 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

Vise Technologies held 5,466 shares of CareDx worth $355K as of Q3 2026.
CareDx was a new Vise Technologies position in Q3 2026.
CareDx made up ﹤0.01% of Vise Technologies's portfolio in Q3 2026, its #1582 holding.
95 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Vise Technologies's 13F filing for Q3 2026, filed 29 Oct 2026.